Loading organizations...
Skull Diamond and Heart Capital operates as a venture capital firm, investing in and developing early-stage companies. It offers a robust, service-based support system designed to foster significant portfolio growth. This comprehensive approach delivers both financial backing and operational assistance, enabling ventures to navigate market complexities effectively.
Chance Wright established the firm in Rochester, New York, in 2020. His vision stemmed from understanding the critical need for specialized support within emerging industries. The founding insight centered on actively catalyzing the growth of promising food and agritech enterprises.
Skull Diamond and Heart Capital serves early-stage ventures in food and agritech, providing resources to mature and expand. Its mission is to empower innovative minds and scale transformative ideas that drive change. By integrating investment with operational guidance, the company helps its portfolio prosper and achieve lasting impact.
Skull Diamond and Heart Capital has 1 tracked investment across 1 company. The latest tracked deal is $5.8M Series B in Plastomics in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 27, 2025 | Plastomics | $5.8M Series B | — | Biogenerator, John Peryam, Lewis And Clark Partners, Missouri Technology Corporation |